Rise of Streptococcus pneumoniae isolates containing both erm(B) and mef(E) genes from an adult tertiary care community hospital system

Diagnostic Microbiology and Infectious Disease
Linda P DiPersioLinda A DeFine

Abstract

The emergence of macrolide- and lincosamide-resistant Streptococcus pneumoniae is a worldwide concern. Of particular interest is the increasing prevalence of erythromycin and clindamycin-resistant isolates containing both erm(B) and mef genes. This study determined the prevalence of erythromycin and clindamycin resistance in 596 clinical S. pneumoniae isolates from 2 adult tertiary care hospitals over a 4-year period (2001-2004). Erythromycin resistance increased from 24% to 34%, but S. pneumoniae isolates resistant to clindamycin as well as to erythromycin increased from 3% in 2001 to 15.5% in 2004 (5-fold increase). Among erythromycin-resistant isolates, those also resistant to clindamycin (MLS(B) phenotype) increased 3-fold (12.8-45%). Of forty-one erythromycin/clindamycin-resistant S. pneumoniae isolates tested, 29 (71%) contained both erm(B) and mef(E) genes. Pulsed-field gel electrophoresis performed on 28 erm(B) + mef(E) positive isolates identified 2 predominant and possibly related clones, which made up 64% of the isolates.

References

Mar 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R DiPersioK Dinsa
Feb 13, 1999·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·A CorsoA Tomasz
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V D ShortridgeR K Flamm
Dec 22, 1999·Emerging Infectious Diseases·G V DoernE Wingert
Sep 3, 2002·The Journal of Antimicrobial Chemotherapy·K WeissUNKNOWN EQUERE project. Etude Quebecoise des pathogènes Respiratoires
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Claire PoyartPatrick Trieu-Cuot
Jun 21, 2005·Emerging Infectious Diseases·David J FarrellKeith P Klugman
Jan 6, 2006·The Pediatric Infectious Disease Journal·Philip ToltzisJeffrey Blumer

❮ Previous
Next ❯

Citations

Aug 24, 2013·The Journal of Antimicrobial Chemotherapy·Aleksandra K WierzbowskiUNKNOWN Canadian Antimicrobial Resistance Alliance
Oct 12, 2007·Expert Opinion on Pharmacotherapy·David Guay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.